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Abstract
MicroRNAs (miRNAs) post-transcriptionally regulate the expression of thousands of distinct mRNAs. While some regulatory
interactions help to maintain basal cellular functions, others are likely relevant in more specific settings, such as response to
stress. Here we describe such a role for the mir-290-295 cluster, the dominant miRNA cluster in mouse embryonic stem cells
(mESCs). Examination of a target list generated from bioinformatic prediction, as well as expression data following miRNA
loss, revealed strong enrichment for apoptotic regulators, two of which we validated directly: Caspase 2, the most highly
conserved mammalian caspase, and Ei24, a p53 transcriptional target. Consistent with these predictions, mESCs lacking
miRNAs were more likely to initiate apoptosis following genotoxic exposure to gamma irradiation or doxorubicin.
Knockdown of either candidate partially rescued this pro-apoptotic phenotype, as did transfection of members of the mir-
290-295 cluster. These findings were recapitulated in a specific mir-290-295 deletion line, confirming that they reflect miRNA
functions at physiological levels. In contrast to the basal regulatory roles previously identified, the pro-survival phenotype
shown here may be most relevant to stressful gestations, where pro-oxidant metabolic states induce DNA damage.
Similarly, this cluster may mediate chemotherapeutic resistance in a neoplastic context, making it a useful clinical target.
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Introduction
MicroRNAs (miRNAs) are endogenous ,22 nt RNAs that
regulate gene expression post-transcriptionally. In animals, the
ability of miRNAs to accomplish this regulation depends on
complementarity between mature miRNA sequences and their
mRNA targets. Most commonly, partial binding of miRNAs leads
to destabilization of mRNA transcripts and/or inhibition of
productive translation, and in rare cases perfect complementarity
instead causes target cleavage. Both in vitro experiments and
bioinformatics have shown that matches to positions 2–7 of the
miRNA, referred to as the miRNA ‘‘seed,’’ are generally required
for effective miRNA-directed mRNA downregulation [1,2].
The roles of miRNAs in mouse embryonic stem cells (mESCs)
have been of particular interest, as this knowledge may shed light
on key aspects of mammalian development and generate useful
insights into reprogramming and cancer, both of which recapit-
ulate aspects of an ESC expression state [3,4]. In addition, the
survival of mESCs in the absence of Dicer (Dcr), the key RNase III
enzyme that generates mature miRNAs, makes them a unique
model system for dissecting miRNA function [5,6]. Several large-
scale sequencing datasets [7,8,9] have revealed that the mir-290-
295 cluster constitutes the dominant miRNA population in
mESCs, giving rise to about 50% of all reads in these cells (Table
S1). Many of the miRNAs in this cluster share the hexamer seed
‘AAGUGC,’ which is also expressed at much lower levels by the
mir-302 and mir-467 clusters, contributing less than 5% of total
reads (Table S2). A similar percent contribution to total miRNA
levels comes from the miR-17-92 family, which contains the
shifted seed ‘AAAGUG,’ and therefore may share some common
targets (Table S2) [7,8,9]. Given the abundance of the mir-290-
295 cluster and these related sequences, much of mESC miRNA
physiology is likely to be a function of this dominant seed
sequence.
Within the mir-290-295 cluster, the ‘AAGUGC’ seed is found in
miR-290-3p, miR-291a-3p, miR-291b-3p, miR-292-3p, miR-294,
and miR-295. Consistent with their high expression, these
miRNAs (which we shall refer to as the mir-295 cluster) have
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maintenance of pluripotency and proliferation. For instance,
miR-290-295 miRNAs have been shown to target Rbl2, which
controls the expression of Dnmt3a and Dnmt3b [10,11],
suggesting a role for this miRNA cluster in regulating de novo
DNA methylation. In addition, miR-290-295 miRNAs have been
found to accelerate cell proliferation by promoting the G1 to S
phase transition through targets such as p21 and Lats2 [12].
However, additional roles for this cluster remain to be elucidated.
Using a combination of target prediction data with microarrays
of mESCs before (Dcr WT) and after (Dcr KO) miRNA loss, as
well as before (295 WT) and after (295 KO) specific deletion of the
mir-295 cluster (Medeiros et al., manuscript in preparation), we
have identified novel targets of the mir-295 cluster in ES cells.
Initial analysis suggested strong enrichment of targets involved in
apoptosis, a function that to date has not been linked to ES-cell
specific miRNAs. Through gain and loss of function studies, we
show that miR-290-295 miRNAs indeed serve a protective
function in preventing mESC apoptosis during exposure to
genotoxic stress. This protective effect appears to be mediated in
part by direct repression of two novel targets, Caspase 2 and Ei24.
As activation of these targets is dependent on DNA damage, we
propose that their regulation may be particularly relevant during
physiological stress in embryonic development. In addition, given
prior indications that these two genes act as tumor suppressors,
misexpression of this cluster in the context of cancer may promote
resistance to standard genotoxic therapeutics.
Results
Predicted targets of the mir-295 cluster are enriched in
pathways regulating apoptosis
In order to identify additional endogenous targets of mESC
miRNAs, we performed expression profiling of mESCs following
Cre recombinase-mediated Dcr deletion using a previously
characterized floxed Dcr mESC line [13,14,15]. As Dcr deletion
leads to slower proliferation [6,12], acute loss was examined in a
polyclonal population, averaging over potential clonal variants and
enriching for initial miRNA-mediated derepression rather than
subsequent compensatory changes. Indeed, expression profiling
from 3 biological replicates taken 5 days following deletion, a time
point by which cells were predominantly Dcr null and a majority
of miRNAs were lost (Figure 1A and 1B), showed better clustering
than 3 chronic deletion cell lines, as indicated by higher Pearson
correlation coefficients (Figure S1). To confirm that targets of the
mir-295 cluster show a transcriptome-wide signature in this
dataset, we calculated a cumulative density function (cdf) plot
comparing expression differences for the set of all mir-295 cluster
targets as determined by Targetscan 5.1 [16]. Relative to a control
set of genes (control) matched for 3’ UTR length, dinucleotide
composition, and expression level, the mir-295 cluster target set
(targets) was more derepressed upon Dcr loss (Figure 1C). An even
larger derepression was seen for conserved mir-295 cluster targets
(conserved targets), suggesting further enrichment of genuine targets
in this set (Figure 1C). This observation supports the utility of these
expression data for target discovery.
To better understand the global effects of miRNA loss in ESCs,
we next performed Gene Ontology (GO) analysis on an initial
candidate set. Enrichment in specific GO categories was tested for
all genes that increased on Dcr loss (defined as $1.2 fold up-
regulation). The top statistically significant categories included
‘‘Regulators of Apoptosis’’ and ‘‘Cell Cycle’’ (p=2.1e
28 and
p=5.6e
25, respectively). We further refined our candidate list
using available array data from the 295 KO line, which also
showed cdf plot signature changes for mir-295 cluster targets
(Figure 1C) (Medeiros et. al., manuscript in preparation). In all, 807
candidates were identified as Targetscan-predicted targets of the
cluster that showed at least a 1.2 fold up-regulation in knockout
populations from both datasets (Figure 2A, Table S3). Over 40%
of upregulated transcripts were shared between the Dcr KO and
295 KO lines, consistent with the finding that the mir-295 cluster
contributes around half of all miRNAs in ES cells. The fact that
this overlap is not even greater may be due to direct and indirect
effects of non-AAGUGC seeds, as there is significantly more
overlap – in fact, closer to 70% – between the two data sets when
considering only those genes that are Targetscan-predicted
AAGUGC targets (p,0.001, Fischer’s exact test).
Several candidate target genes were selected for further
examination based on their degree of upregulation in Dcr KO
and 295 KO cells, as well as their functional annotations. The
tested targets span a range of biological functions and processes,
from cell cycle regulators Lats2 and p21 to immunological signal
transduction components Irf9 and Irak3. Their 3’ UTRs were
cloned into luciferase constructs, and expression levels between
Dcr WT and Dcr KO cells were evaluated (Figure 2B). All
candidates tested displayed at least mild repression relative to a
control construct lacking miRNA target sites, ranging from strong
(,5-fold) to modest (,30%) down-regulation. The magnitude of
repression for the previously identified miR-295 targets Lats2 and
p21 was comparable to that observed previously [12]. Additional
transfection studies confirmed that repression could be conferred
specifically by miR-295 in a Dcr KO background (Figure S2).
These in vitro results support the enrichment of our candidate list
for true miR-295 targets.
Caspase 2 and Ei24, key apoptotic mediators, are direct
targets of the mir-295 cluster
We chose to more closely examine one of the most strongly
down-regulated reporter targets, Caspase 2 (Casp2), along with
Ei24, as these targets could provide a novel link between ESC-
specific microRNAs and cell survival. Casp2, an initiator of
apoptosis in response to genotoxic stress [17], has four AAGUGC
binding sites in its 3’ UTR. Quantitative RT-PCR analysis
demonstrated an approximately 5-fold increase in Casp2 tran-
script levels in Dcr KO cells, consistent with the degree of
Author Summary
In this study, we were interested in learning more about
the roles of microRNAs—small segments of RNA that help
turn off genes—during early development. By studying
mouse embryonic stem cells, a unique cell type that can
give rise to all adult tissues, we found that a number of
genes related to cell survival appeared to be affected by
global microRNA loss. Interestingly, these changes in gene
expression did not lead to large increases in cell death
during normal cell growth, but rather became apparent
when cells were treated with agents that cause DNA
damage, like the chemotherapeutic doxorubicin and
gamma irradiation. Our results suggest that these micro-
RNAs may provide robustness for mammalian develop-
ment, ensuring proper development despite variations in
blood flow and oxygen tension, known to cause DNA
damage. Given that certain cancers share features of the
embryonic state, including rapid proliferation and lack of
differentiation, our results also suggest that the re-
expression of these microRNAs in tumors may confer
resistance to chemotherapeutic drugs.
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(Figure 3A). This observation indicates that the majority of
miRNA repression likely occurs at the level of transcript stability.
In support of the reporter assay, Dcr KO cells showed a
comparable increase in Casp2 at the protein level, which could
be partially rescued by transfection of either miR-295, miR-467a
(which shares the same hexamer seed), or a Casp2 siRNA, but not
by siRNAs against other unrelated targets (Figure 3B). Transfec-
tion of miR-295 also strongly repressed an intact Casp2 reporter in
these cells, but not a reporter in which the four target sites were
mutated (Figure 3C). Combinatorial mutagenesis revealed that
repression was not conferred equally by these four sites, as much of
the repression was lost by mutation of the first two sites alone
(Figure 3D). Taken together, these data suggest that direct
miRNA-mediated repression of Casp2 leads to approximately 5-
fold repression, making it one of the most potently repressed mir-
295 cluster targets identified to date.
We additionally characterized the novel target Ei24, which has
also been implicated in apoptosis. Originally identified as a direct
p53 transcriptional target that binds Bcl2 [18,19], the Ei24 3’
UTR contains one 7mer miR-295 site. The 3’ UTR of Ei24 fused
to a luciferase reporter conferred approximately 2-fold repression
in Dcr WT cells relative to Dcr KO cells, an effect that could be
restored following transfection of miR-295 (Figure 3C). Notably,
repression was lost upon mutation of the seed site, confirming that
Ei24 is a direct target.
Mir-295 cluster miRNAs promote survival of ES cells
during genotoxic stress
Based on these repression data as well as the earlier informatic
predictions, we tested whether mir-295 cluster miRNAs could
modulate apoptosis in mESCs. The basal apoptosis rates of Dcr
WT and KO ES cells in a 24 h period were compared by staining
them with antibodies against cleaved Caspase 3 (Casp3) and then
analyzing cells by flow cytometry. Under these conditions, only
modest basal apoptotic rates were observed, with Dcr KO ES cells
showing a slightly higher apoptosis rate than Dcr WT cells
(Figure 4A, Figure S3A). Given that ESCs are highly sensitive to
DNA damage [20] and both validated targets have been
implicated in the DNA damage response, we hypothesized that
the mir-295 cluster may be specifically protective in the context of
genotoxic stress. To test this, we first examined the effect of
exposing WT and Dcr KO cells to gamma irradiation or
doxorubicin. Gamma irradiation induces DNA damage and
activates ATM and p53, as does doxorubicin, a topoisomerase II
inhibitor [21]. These signals lead to activation of the intrinsic
apoptosis pathway and result in the cleavage of Casp3 [22]. We
were able to confirm this cleavage product by Western blot in our
cell culture system, as well as cleavage of Nanog, a previously
reported Casp3 target [23] (Figure S5A). We also observed a
decrease in Casp2 levels and the appearance of the previously
described 35kD cleavage product [24], confirming its activation in
our system (Figure S5B). Because this band was specific to DNA
Figure 1. Acute Dicer deletion and specific mir-295 cluster deletion show global target derepression signatures. A. PCR for
confirmation of Dicer loss on acute deletion. Dicer floxed and floxed-deleted bands were amplified over a nine day time course to determine the
point of maximal enrichment for Dicer null cells. B. Northern blot for mature miRNAs following Dicer deletion. A DNA probe for the abundant miR-292
was assessed at 5, 7, and 9 days following Dicer deletion, with a probe for U6 to control for loading. C. Cumulative distribution functions (cdfs) of log2
fold change (LFC) in mRNA expression between Dcr WT and Dcr KO ES cells (top panel) and 295 WT and 295 KO ES cells (bottom panel) are plotted.
Plots include conserved targets (red line), all predicted miR-295 targets (blue line), and control mRNAs (grey line). targets include ,3000 predicted
TargetScan targets of the miR-295 cluster. Conserved targets contains the ,300 genes in the top 10% of targets ranked by TargetScan 5.1 branch
length scores. The control mRNA set was selected to match the predicted targets in expression, 3’ UTR length and composition. Targets are
derepressed in both Dcr KO as well as 295 KO mESCs (p#2.2e
216 and p=9.7e
29 by rank sum test, respectively). Similarly, conserved targets are
derepressed in both Dcr KO as well as 295 KO mESCs (p#2.2e
216 and p=3.1e
214 by rank sum test, respectively).
doi:10.1371/journal.pgen.1002054.g001
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appears to be insufficient to generate autocleavage. Both Dcr WT
and KO ES cells showed minimal Casp3 activation immediately
after 5-Gy gamma-irradiation, in line with previous descriptions of
a 1–2 h lag phase in its activation (Figure 4A) [25]. However, there
was a notable difference in their responses 24 h after the treatment
(and to a lesser extent 10 h after treatment, Figure S4A); while
10% of WT cells became apoptotic, more than 30% of the Dcr
Figure 2. Microarray data and Targetscan predictions identify candidate miR-295 targets in mESCs. A. Venn diagram of microarray and
target prediction data used to generate mir-295 cluster target candidates. ‘‘mir-295 cluster predicted targets’’ = predicted TargetScan targets of the
miR-295 cluster; ‘‘295 KO’’ = genes that showed a 1.2 fold upregulation on mir-295 cluster loss; ‘‘Dcr KO’’ = genes that showed a 1.2 fold
upregulation on Dicer loss. Only ES-expressed genes (i.e. genes with an expression of at least 16 on the wild type arrays) were considered for analysis.
B. Activity of luciferase reporters of predicted targets of the mir-295 cluster were assayed in Dcr WT and Dcr KO ES cells. Luciferase reporters contain
full length 3’ UTRs of predicted targets. Relative luciferase activity is the ratio of the reporter’s activity in WT ES cells and Dcr KO ES cells.
doi:10.1371/journal.pgen.1002054.g002
Figure 3. The pro-apoptotic genes Caspase 2 (Casp2) and Ei24 are direct targets of the mir-295 cluster. A. RT-PCR of Casp2 mRNA in Dcr
KO cells. B. Western blot of Casp2 in Dcr WT and Dcr KO ES cells. 50 nM miR-295, miR-467a, Bim siRNA, Casp2 siRNA and Ei24 siRNA were transfected
into Dcr KO ES cells, and Casp2 protein expression was assayed 24 hours later. miR-467a shares the same hexamer seed with miR-295, and Bim siRNA
and Ei24 siRNA served as negative controls. C. Luciferase reporters with a full length Casp2 3’ UTR or Ei24 3’ UTR, as well as their seed mutant versions
were assayed by comparing their activities in Dcr WT and Dcr KO ES cells. Casp2:4M has all 4 AAGUGC seed binding sites mutated, and Ei24:1M has its
single AAGUGC seed binding site mutated. 20 nM miR-295 was transfected into Dcr KO ES cells and the relative activity measured versus non-
transfected cells to test if the repression of luciferase reporters is specifically due to AAGUGC miRNAs. D. Casp2 luciferase reporters bearing different
combinations of AAGUGC seed binding site mutations were tested in Dcr WT and Dcr KO ES cells. Casp2:2, 2nd AAGUGC binding site was mutated;
Casp2:3,4, 3rd and 4th binding sites were mutated; Casp2: 2,3,4, 2nd, 3rd, and 4th binding sites were mutated; Casp2:1,2, 1st and 2nd binding sites
were mutated; Casp2: 1,2,3,4, all binding sites were mutated. n$3 for all experiments, and results are shown as mean 6 S.E.M. (standard error of the
mean). P-values were obtained by t-tests, * denotes p # 0.05, and ** denotes p # 0.01.
doi:10.1371/journal.pgen.1002054.g003
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seen using Annexin V staining, a complementary assay for
detecting early apoptosis (Figure S3C). Importantly, mature
miRNA levels from the mir-295 cluster were unchanged by these
stressors (Figure S3D). Therefore, it appears that loss of mature
miRNAs leads to an enhancement of apoptosis in the presence of
DNA damage.
To examine whether the miR-295 targets modulated apoptosis,
we transfected a series of siRNAs into Dcr KO cells and evaluated
cell death following irradiation. The difference in Casp3 activation
between 0 and 24 h timepoints was calculated in order to account
for differences in transfection-specific toxicity (Figure S6A and
S6B). Relative to control siRNAs, transfection of miR-290-3p or
miR-295 drastically decreased the apoptosis response of Dcr KO
cells to gamma irradiation (Figure 4B, Figure S6A and S6B). The
reduction in apoptosis is specific to the AAGUGC seed, as seed
mutants failed to rescue Dcr KO ES cells from apoptosis. When
we applied siRNAs specific to each validated target, or to Bim, a
well-characterized proapoptotic factor, cells exhibited a decrease
of 5–10% in Casp3 activation 24 h after irradiation, a level similar
to mir-295 cluster miRNA overexpression (Figure 4B, Figure S6A
and S6B). Similar findings were obtained when cells were treated
with 100 nM –300 nM doxorubicin, suggesting that the identified
pathways are relevant to DNA damage in general (Figure 4C and
4D, Figure S4B, Figure S6C and S6D).
Specific deletion of the mir-295 cluster enhances
susceptibility to apoptosis upon DNA damage
Because deletion of Dcr involves global miRNA loss, and three
additional clusters containing the same or similar hexamer seed,
mir-302, mir-467, and mir-17-92, are expressed in ESCs (Table
S2), we examined the 295 KO line to determine the specific
Figure 4. Downregulation of Casp2 and Ei24 partially rescues the increased apoptotic rate of Dcr KO cells following genotoxic
stress. A. The percentage of cells expressing cleaved Caspase 3 (Casp3) in Dcr WT and Dcr KO ES cells after exposure to 5-Gy radiation (0 and
24 hours after radiation treatment). Cleaved Casp3 was assayed by flow cytometry, and was used to estimate apoptotic response. Apoptosis rate of
Dcr KO cells is shown in black bars, and that of WT cells is shown in white bars. B. Dcr KO cells were treated with 5-Gy radiation 24 hours after
transfection of 50 nM miR-295, miR-290-3p, Bim siRNA, Casp2 siRNA or Ei24 siRNA. Casp3 activity was assayed 0 and 24 h after the treatment, and the
difference in apoptosis rate is shown. Transfection of seed mutants and control siRNAs into Dcr KO cells, and transfection of control siRNAs into WT
cells served as controls. C,D. A similar series of experiments was performed in Dcr WT and Dcr KO cells using 100 nM doxorubicin. n$3 for all
experiments. Results are shown as mean 6 S.E.M. P-values were obtained by Mann-Whitney tests, * denotes p#0.05, and ** denotes p#0.01.
doi:10.1371/journal.pgen.1002054.g004
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deletion offers the best insight into physiological function as it
avoids overexpression artifacts of exogenous miRNAs or toxicity
effects of miRNA inhibitors. This system also avoids confounding
by alternative miRNA-independent roles for Dcr itself in cell
survival, as have been recently reported in C. elegans [26]. We first
re-examined the reporter constructs for Casp2 and Ei24 in the 295
KO ESC line relative to its wild-type counterpart. In this context,
the Casp2 reporter was derepressed approximately half as strongly
as it was in Dcr KO cells, suggesting that the miR-302 and miR-
467a families of miRNAs incompletely compensate for loss of the
mir-295 cluster (Figure 5A). This partial derepression in the mir-
295 cluster deletion probably reflects the quantitative change in
the total level of AAGUGC seed miRNAs, as exogenous miR-295
could further repress Casp2 protein levels (Figure 5B). We next
exploited 295 KO ES cells to determine whether these cells had an
increase in apoptosis upon exposure to DNA damaging agents.
295 WT and KO ES cells were irradiated and the level of cleaved
Casp3 activity was measured 0 and 24 h after treatment
(Figure 5C, Figure S3B). As expected, 295 KO cells were much
more sensitive to irradiation than their WT counterparts
(Figure 5C). Again, overexpression of two miRNAs in the cluster,
miR-290-3p and miR-295, reduced the rate of apoptosis
(Figure 5D, Figure S7A and S7B). In addition, knockdown of
the validated targets Casp2 or Ei24, or the pathway component
Bim, partially rescued cells from apoptosis caused by irradiation
(Figure 5D, Figure S7A and S7B). We repeated these experiments
with 100 nM doxorubicin as before, obtaining similar results
(Figure 5E and 5F, Figure S7C and S7D). Therefore, deletion and
restoration of mir-295 cluster miRNAs recapitulate the modula-
tion of apoptosis rates seen in a Dcr null context.
Discussion
Here, we provide the first demonstration that the mir-295
cluster can suppress apoptosis in mESCs following exposure to the
genotoxic stressors ionizing irradiation and doxorubicin. Initially
suggested by an informatic comparison of global expression data
following Dicer loss, the link between ESC miRNAs and cell death
may act in part through the novel targets Casp2 and Ei24. In the
case of Casp2, this appears to occur through multiple seed match
sites in the 3’ UTR leading to a roughly 5 fold reduction in
expression, while for Ei24, targeting is achieved through just a
single complementary site conferring approximately a 2 fold
repression.
Although the exact functions of these two mediators are still
emerging, multiple lines of evidence suggest that they are
important in cell survival. Initial studies of Casp2 knockout mice
showed increased numbers of oocytes suggesting resistance to cell
death, which was confirmed by their decreased sensitivity to
doxorubicin [27]. Subsequent studies have extended this pro-
survival phenotype of Casp2 loss to include a number of tissues
and DNA damaging agents [28]. Ei24, which was originally
identified in a screen for etoposide-induced transcripts, has been
shown to promote cell death by binding and sequestering Bcl2
[19].
Interestingly, these genes as well as several previously identified
miR-295 family targets are known to be directly or indirectly
associated with p53. Indeed, Pathway Analysis of well-character-
ized miR-295 targets brought up a single significant network
(p=10
214), ‘‘Cell Death, Cell Cycle, Cellular Function and
Maintenance,’’ which prominently featured p53 (Figure 6).
Activation of Casp2 can occur through a protein complex in
which it associates with the p53 target PIDD [28]. Ei24 itself is a
p53 transcriptional target, identified as one of 14 genes induced by
adenoviral transfection of p53 into a p53-null colon cancer cell line
[19]. We additionally confirmed two previously identified miR-
295 targets, p21 (also known as Cdkn1a) and Lats2 [29]. In the
case of p21, direct activation by p53 promotes cell cycle arrest at
the G1/S phase [30]. Lats2, while also induced by p53, exists in a
positive feedback loop with p53 in which it binds and inhibits
Mdm2, thereby activating p53 [31]. Thus, miR-295 family
miRNAs target a number of p53 associated genes and in all cases
antagonizing p53 activation, consistent with the protective effect
we have identified here.
Like p53, the mir-295 cluster affects both arms of cellular
proliferation, namely cell death and cell cycle progression [12,29].
Unlike cell cycle progression, however, the anti-apoptotic role is
likely to have the greatest developmental consequences following
DNA damage, induced physiologically by oxidative stress or
metabolites. Interestingly, even simply ex vivo cell passage may be
sufficient to induce a low level of stress, as evidenced by the slightly
higher apoptotic rate of Dicer null cells under basal culture. In
their pro-survival capacity, these miRNAs may confer robustness
during embryonic development, as has been demonstrated in
Drosophila. For instance, miR-7 has been shown to participate in a
complex network of feedback loops to ensure proper photorecep-
tor cell development despite temperature fluctuations in develop-
ment [32]. Similarly, miR-263a/b appear to prevent patterning
defects in bristle formation, again consistent with the notion that
they promote the fidelity of developmental trajectories [32,33].
Early phenotypic data from mir-290-295 KO mice suggests an
incompletely penetrant gestational phenotype (Medeiros et. al.,
manuscript in preparation), supporting the model that loss of this
cluster is tolerated in certain developmental scenarios, perhaps
including those with limited stressors during gestation.
Beyond regulating development, the miRNAs described here
may also have important consequences for cancer, as both Casp2
and Ei24 are considered tumor suppressors. In the case of Casp2,
this has been best demonstrated in the Eu-myc lymphoma model,
where loss of even a single copy of Casp2 can accelerate malignant
transformation [34]. Similarly, Ei24 is found in a region that shows
frequent loss-of-heterozygosity in solid tumors, and its loss has
been associated with increased breast cancer invasiveness [19]. In
addition, knockdown of Ei24 in mouse fibroblasts or human breast
cancer cell lines leads to increased resistance against etoposide-
induced apoptosis [19,35]. Consistent with these findings, the mir-
295 cluster itself has been speculated to be an ‘‘oncomir’’ cluster,
as overexpression of its human homolog, the mir-371-373 cluster,
has been found in various human tumors [36,37,38] and may
promote malignant transformation [39]. Given our findings, we
hypothesize that these miRNAs may have a survival promoting
function with dual effects, helping cells navigate physiological
stresses during development, and helping cancer cells maintain
viability in the face of genotoxic chemotherapeutic agents.
In conclusion, these data expand our understanding of ESC
miRNA function, linking the ES cell specific miR-295 family to
key players in cell death. Further, this analysis reveals a complex
relationship between embryonic stem cell miRNA regulation and
p53 activation.
Materials and Methods
ES cell culture
Feeder-free Dicer1
flox/flox and Dicer1
2/2 mouse embryonic
stem cells (mESCs) were generated and maintained on gelatin as
described previously [40]. mESCs cells containing a floxed and
excised mir-295 cluster were generated in a similar manner and
A Novel Anti-Apoptotic Role for Mir-290-295
PLoS Genetics | www.plosgenetics.org 6 May 2011 | Volume 7 | Issue 5 | e1002054Figure 5. Loss of the mir-295 cluster derepresses Casp 2 and Ei24 3’ UTRs and enhances sensitivity to DNA damaging agents.
A. Luciferase reporters with full length versions of the Casp2 3’ UTR or Ei24 3’ UTR, as well as their seed mutant versions were assayed in 295 WT and
295 KO ES cells. B. Western blot of Casp2 in 295 WT and 295 KO ES cells. 50 nM miR-295, miR-467a, and miR-20a were transfected into 295 KO ES cells,
and Casp2 protein expression was assayed 24 hours after the transfection. C. The percentage of cells with cleaved Casp3 in 295 WT and 295 KO ES
cells after exposure to 5-Gy radiation (0 and 24 hours after radiation treatment). Cleaved Casp3 was assayed by flow cytometry, and was used to
estimate apoptotic response. Apoptosis of 295 KO cells is shown in black bars, and that of 295 WT cells is shown in white bars. D. Cells were
transfected with 50 nM siRNAs as shown, and difference in apoptotic response of 295 WT and 295 KO ES cells 24 hours after exposure to 5-Gy
radiation was plotted. E,F. A similar series of experiments was performed on 295 WT and 295 KO cells after exposure to 100 nM doxorubicin. n$3 for
all experiments. Results are shown as mean 6 S.E.M. (standard error of the mean). P-values were results of Mann-Whitney tests, and * denotes
p#0.05, and ** denotes p # 0.01.
doi:10.1371/journal.pgen.1002054.g005
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Oligos and siRNAs used in all the experiments
See Table S4.
Generation of luciferase constructs, mESC transfection,
and luciferase assays
MicroRNA mediated repression of each candidate gene was
tested by cloning PCR amplified products corresponding to the
entire 3’ UTR downstream of a pRL-CMV Renilla luciferase
reporter as described previously [41]. Nucleotides 5–7 of Casp2,
Bim, and Ei24 binding sites were mutated by Quickchange site-
directed mutagenesis. Digests were performed using either XhoI
or SalI to give the 5’ site and ApaI or NotI to give the 3’ site.
Firefly luciferase (pGL3) was used as a transfection control. Data
shown are summaries of three or more independent trials.
24 hours before transfection 1e
5 mESC cells were plated/well of
gelatinized 24-well plate. Cells were transfected with 2 ml
Lipofectamine 2000 (Invitrogen), 0.1 mg of CMV-GFP plasmid
(Invitrogen), 0.7 mg of pWS (carrier plasmid), and 50 nM siRNAs
in 300 ml of Opti-MEM (Invitrogen). 4 hours after transfection,
transfection mix was removed from cells and replaced with ESC
media. 24 hours after transfection, cells were lysed with 1X Passive
Lysis Buffer (Promega) and Dual luciferase was measured using
Dual Luciferase reporter assay system (Promega) according to
manufacturer’s instructions.
Northern Blot analysis
Total RNA was isolated from ES cells with or without acute
Dicer deletion using Trizol (Invitrogen), following the standard
protocol. Approximately 50 mg of each RNA was loaded onto a
15% denaturing MOPS gel, according to the Northern Blot
protocol outlined previously [42]. Membranes were probed for
Figure 6. Ingenuity Pathway Analysis (IPA) of miR-295 targets. IPA was performed for validated targets of miR-295 from this and prior studies
[10,11,12], and identified the network, ‘‘Cell Death, Cell Cycle, Cellular Function and Maintenance,’’ which centers around p53. Solid lines indicate
direct interactions and dashed lines indicate indirect interactions. Validated targets of miR-295 are shown in red and computationally predicted
targets are shown in orange.
doi:10.1371/journal.pgen.1002054.g006
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to hybridizing with a different probe, membranes were stripped by
incubating the membrane in boiling 0.1% SDS for 30 minutes and
loss of signal was confirmed prior to rehybridization.
Western Blot analysis
24 hours after transfection with short RNAs, Dicer1
2/2,
Dicer
flox/flox, miR-290-295
2/2, or miR-290-295
flox/flox cells were
lysed in RIPA buffer (1% NP40, 0.5% sodium deoxycholate, 0.1%
SDS, in pH 7.4 PBS) containing protease inhibitors. 30–50 mg
lysate was loaded onto 8–12% Bis-Tris gels (Invitrogen) and wet-
transferred at 4uC to Westran PVDF membranes for 2 h at 70V.
After 1 h blocking at room temperature in 5% milk-TBST,
membranes were probed overnight at 4uC with 1:2000 mouse
anti-vinculin (Santa Cruz Biotechnology) or 1:200 rat anti-Caspase
2 (Millipore, 10C6). After 2610 min. TBST washes, membranes
were probed for 1 h at room temperature with 1:2000 corre-
sponding hRP-conjugated secondary, washed an additional
2610 min. in TBST, and visualized using Western Lightning
Plus ECL (PerkinElmer).
RT-PCR
Trizol (Qiagen) was used to extract RNA from Dicer1
flox/flox and
Dicer1
2/2 cells. A Superscript III kit (Invitrogen) was used to
reverse transcribe 1 mg RNA following DNAse treatment with the
Turbo-DNA free kit (Ambion), and real time PCR was performed
with the primer sequences listed, using beta actin for normalization.
Transfection and Casp3 assays
24 hours before transfection 2e
5 mESC cells were plated/well of
gelatinized 12-well plates. Cells were transfected with 4 ml
Lipofectamine 2000 (Invitrogen), 0.2 mg pCAGGS-mCherry plas-
mid, 1.4 mg of pWS, and 50 nM of siRNA in 600 ml of Opti-MEM
(Invitrogen). 4 hours after transfection, transfection mix was
removed from cells and replaced with ESC media. 24 hours after
transfection, cells were exposed to 5-Gy gamma radiation or
100 nM doxorubicin. Immediately after exposure, one plate of cells
were trypsinized and fixed with 16 BD Perm buffer. Cells were
stained with Rabbit Anti-Casp3 antibody (BD Biosciences) at 1:100
for 20 min. at room temperature. Following washing, cells were
incubated with Alexa-488-conjugated secondary antibody (diluted
1:250) (Invitrogen) for 60 min. at room temperature, washed, and
resuspended in BD FACS buffer containing 1:5000 Hoechst stain.
24 hours after the treatment, another plate of cells was trypsinized
and treated with the same protocol for FACS analysis.
Casp3 assays were also performed on Dcr KO and WT mESCs
without transfection. 24 hours before collecting cells for the 0 h
time point for Casp3 assay, 2e
5 mESC were plated/well of
gelatinized 6-well plates. In the context of genotoxic stress,
4e
5 mESCs were plated/well of gelatinized 6-well plates. 24 hours
after plating, cells were treated with 5-Gy radiation or 100 nM
doxorubicin. Casp3 assays were performed at 0 h and 24 h after
the treatment following the same protocol described above.
Annexin V assays
4e
5 mESCs were plated/well of gelatinized 6-well plates. 24 h after
plating, cells were exposed to 100 nM doxorubicin. Cells were
trypsinized0 hand 24 hafterthe treatmentforAnnexinV detection,
following Annexin V-FITC apoptosis detection kit (BD Biosciences).
Microarray analysis
Microarray analysis was performed 5 days following transfection
of Dicer
flox/flox wild-type cells with either GFP alone or GFP and
Cre recombinase, and data were analyzed using biological
triplicates. Microarrays for the mir-295 cluster deletion were
performed on two deletion and two wild-type lines independently
derived. Spot replicates were condensed using geometric means.
The log fold change (LFC) value for Dcr WT/Dcr KO was
defined as the difference between the mean log expression in Dcr
WT cells and the mean log expression in Dcr KO cells. The
conserved set of targets were downloaded from TargetScan-
Mouse5.1 website (http://www.targetscan.org/mmu_50/). To
identify targets predicted for the AAGUGC seed family, we
looked at all miRNAs that contain AAGUGC in their seed region.
More specifically, they include ‘‘miR-291b-3p/519a/519b-3p/
519c-3p’’, ‘‘miR-290-3p/292-3p/467a’’, ‘‘miR-467cd’’, ‘‘miR-
106/302’’, and ‘‘miR-467b’’. We excluded all the targets of
‘‘miR-302ac/520f’’, as well as T1A 7mer targets of ‘‘miR-467b’’,
as they do not contain the 6-mer match to AAGUGC. Targets
with top 10% of branch length scores were considered
‘‘conserved’’.
Gene Ontology and Pathway analysis
Gene Set Analysis Toolkit (http://bioinfo.vanderbilt.edu/
webgestalt/) was used to perform GO analysis. Targets and
controls were generated as described in the text. Network data
were analyzed through the use of Ingenuity Pathways Analysis
(Ingenuity Systems, www.ingenuity.com). Ingenuity Pathway
Analysis (IPA) was performed on the set of validated miR-295
targets to identify the most strongly associated canonical pathways.
Statistical analyses
All test statistics were calculated using R (http://www.r-project.
org). The Wilcoxon rank sum test was used because it does not
assume normality of the underlying distributions. T-tests and
Kolmogorov–Smirnov (KS) test using these data gave generally
similar results.
Supporting Information
Figure S1 Microarray data from polyclonal acute dicer deletion
samples show better inter-sample correlation than data from clonal
chronic dicer deletion lines. Biological triplicates were obtained for
both 5 days post Dicer deletion (Acute 1-3) and over 1 month
following Dicer deletion (Chronic 1-3), after which samples were
normalized together. Pearson correlations for all pairwise compa-
risons within the two conditions are shown here.
(PDF)
Figure S2 Repression of predicted targets of the miR-295 cluster
in Dcr WT and Dcr KO ES cells. Activity of luciferase reporters of
predicted targets were assayed in WT, Dcr KO ES cells, as well as
in Dcr KO ES cells after over expression of 20 nM miR-295. n$2,
and results are shown as mean 6 S.E.M.
(PDF)
Figure S3 Comparison of WT and KO cells’ apoptosis response
to stress. A. The percentage of cells expressing cleaved Caspase 3
(Casp3) in WT and Dcr KO ES cells under normal culturing
conditions (0 and 24 hours after plating). B. The percentage of cells
expressing cleaved Caspase 3 (Casp3) in 295 WT and 295 KO ES
cells under normal culturing conditions (0 and 24 hours after
plating). Cleaved Casp3 was assayed by flow cytometry, and was
used to estimate apoptosis response. Apoptosis of KO cells is
shown in black bars, and that of WT cells is shown in white bars.
C. Annexin V positive cells were assayed by flow cytometry
immediately or 24 h after exposure to 100 nM doxorubicin. n=2,
and results are shown as mean 6 S.E.M. (standard error of the
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ES cells, and WT ES cells 6 hours after 2 mM doxorubicin
treatment.
(PDF)
Figure S4 Time course of WT and KO cells’ apoptosis response
to stress. A. WT and Dcr KO ES cells were treated with 5-Gy
radiation. Casp3 activity was assayed 0 h, 10 h, and 24 h after the
treatment, and the differences in apoptosis rate (between 10 h and
0 h, and between 24 h and 0 h) are shown. Cleaved Casp3 was
assayed by flow cytometry, and was used to estimate apoptosis
response. Apoptosis rate of Dcr KO cells is shown in black bars,
and that of WT cells is shown in white bars. n=2, and results are
shown as mean 6 S.E.M. B. WT and Dcr KO cells were treated
with 2 doses of doxorubicin (200 nM and 300 nM). Casp3 activity
was assayed 0 h, 10 h, and 24 h after the treatment, and the
differences in apoptosis rate (between 10 h and 0 h, and between
24 h and 0 h) are shown. n=1 with 3 technical replicates, and
results are shown as mean 6 standard deviation.
(PDF)
Figure S5 Analysis of Caspase 2 and Caspase 3 cleavage upon
DNA damage induction. A. Dcr KO cells treated with 2 mM
doxorubicin for 6 hours. Blot was probed with an antibody specific
for cleaved Caspase 3 and for its target, Nanog, before and after
treatment. B. Dcr KO and Dcr WT cells following 2 mM
doxorubicin treatment for 6 hours. Intact Caspase 2 (49 kD) and
cleaved Caspase 2 (35 kD) are both shown.
(PDF)
Figure S6 Raw data of Dcr KO and WT cells’ apoptosis
response after treatment of 5-Gy radiation or 100 nM doxorubi-
cin. A. Dcr KO cells were treated with 5-Gy radiation 24 hours
after transfection of 50 nM miR-295 or miR-290-3p. Caspase 3
activity was assayed 0 and 24 h after the treatment. Transfection of
seed mutants and control siRNAs (50 nM) into Dcr KO cells, and
overexpression of control siRNAs (50 nM) into WT cells served as
controls. B. Dcr KO cells were treated with 5-Gy radiation 24
hours after transfection of 50 nM siRNAs against Bim, Casp2, and
Ei24. Caspase-3 activity was assayed 0 and 24 h after the
treatment. C,D. A similar series of experiments was performed in
Dcr WT and Dcr KO cells using 100 nM doxorubicin. n $ 3 for
all experiments. Results are shown as mean 6 S.E.M. (standard
error of the mean).
(PDF)
Figure S7 Raw data of 295 KO and 295 WT cells’ apoptosis
response after treatment of 5-Gy radiation or 100 nM doxorubi-
cin. A. 295 KO cells were treated with 5-Gy radiation 24 hours
after transfection of 50 nM of miR-295 or miR-290-3p. Caspase 3
activity was assayed 0 and 24 h after the treatment. Transfection of
seed mutants and control siRNAs (50 nM) into 295 KO cells, and
overexpression of control siRNAs (50 nM) into 295 WT cells
served as controls. B. 295 KO cells were treated with 5-Gy
radiation 24 hours after transfection of 50 nM siRNAs against
Bim, Casp2, and Ei24. Caspase-3 activity was assayed 0 and 24 h
after the treatment. C,D. A similar series of experiments was
performed in 295 WT and 295 KO cells using 100 nM
doxorubicin. n $3 for all experiments. Results are shown as
mean 6 S.E.M. (standard error of the mean).
(PDF)
Table S1 Sequences and expression level of the mir-295 cluster
in ES cells. The 6-mer seed is highlighted in bold. The cloning
statistics were taken from previously published studies [7,8,9].
(PDF)
Table S2 Sequences and expression level of the mir-302, mir-
467, and mir-17-92 clusters in ES cells. The 6-mer seed is
highlighted in bold. The cloning statistics were taken from
previously published studies [7,8,9].
(PDF)
Table S3 Predicted targets of the mir-295 cluster.
(PDF)
Table S4 Oligos and siRNAs used in all experiments.
(PDF)
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